本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

烏龍製藥

14.34
+0.30002.14%
盤前14.340.00000.00%08:56 EDT
成交量:77.59萬
成交額:1,107.47萬
市值:6.61億
市盈率:-4.71
高:14.49
開:14.30
低:14.00
收:14.04
資料載入中...
2024/03/04

重要事件披露

Form 8-K - Current report
2024/03/01

重要事件披露

Form 8-K - Current report
2024/02/22

超過5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/02/15

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/13

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/07

重要事件披露

Form 8-K - Current report
2024/02/01

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/02/01

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/01/18

重要事件披露

Form 8-K - Current report
2024/01/02

重要事件披露

Form 8-K - Current report
2023/12/29

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/11/28

SEC問詢函

Form CORRESP - Correspondence
2023/11/15

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2023/11/14

重要事件披露

Form 8-K - Current report
2023/11/14

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/09/16

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/09/13

SEC問詢函

Form CORRESP - Correspondence